5325402025-04-012025-06-305325402025-06-305325402025-04-012025-06-30in-capmkt:OtherExpenses1Member5325402025-04-012025-06-30in-capmkt:OtherExpenses2Member5325402025-04-012025-06-30in-capmkt:ReportableSegments1Member5325402025-04-012025-06-30in-capmkt:ReportableSegments2Member5325402025-04-012025-06-30in-capmkt:ReportableSegments3Member5325402025-04-012025-06-30in-capmkt:ReportableSegments4Member5325402025-04-012025-06-30in-capmkt:ReportableSegments5Member5325402025-04-012025-06-30in-capmkt:ReportableSegments6Member5325402025-04-012025-06-30in-capmkt:ReportableSegments1Member5325402025-04-012025-06-30in-capmkt:ReportableSegments2Member5325402025-04-012025-06-30in-capmkt:ReportableSegments3Member5325402025-04-012025-06-30in-capmkt:ReportableSegments4Member5325402025-04-012025-06-30in-capmkt:ReportableSegments5Member5325402025-04-012025-06-30in-capmkt:ReportableSegments6Member5325402025-04-012025-06-30in-capmkt:ReportableSegments1Member5325402025-06-30in-capmkt:ReportableSegments1Member5325402025-04-012025-06-30in-capmkt:ReportableSegments2Member5325402025-06-30in-capmkt:ReportableSegments2Member5325402025-04-012025-06-30in-capmkt:ReportableSegments3Member5325402025-06-30in-capmkt:ReportableSegments3Member5325402025-04-012025-06-30in-capmkt:ReportableSegments4Member5325402025-06-30in-capmkt:ReportableSegments4Member5325402025-04-012025-06-30in-capmkt:ReportableSegments5Member5325402025-06-30in-capmkt:ReportableSegments5Member5325402025-04-012025-06-30in-capmkt:ReportableSegments6Member5325402025-06-30in-capmkt:ReportableSegments6Member5325402025-04-012025-06-30in-capmkt:ReportableSegments1Member5325402025-06-30in-capmkt:ReportableSegments1Member5325402025-04-012025-06-30in-capmkt:ReportableSegments2Member5325402025-06-30in-capmkt:ReportableSegments2Member5325402025-04-012025-06-30in-capmkt:ReportableSegments3Member5325402025-06-30in-capmkt:ReportableSegments3Member5325402025-04-012025-06-30in-capmkt:ReportableSegments4Member5325402025-06-30in-capmkt:ReportableSegments4Member5325402025-04-012025-06-30in-capmkt:ReportableSegments5Member5325402025-06-30in-capmkt:ReportableSegments5Member5325402025-04-012025-06-30in-capmkt:ReportableSegments6Member5325402025-06-30in-capmkt:ReportableSegments6Member5325402025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15325402025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25325402025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15325402025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss25325402025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss35325402025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss45325402025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532540TCSNOTLISTEDINE467B01029Tata Consultancy Services LimitedMain BoardEquity2025-04-012026-03-312025-07-102025-06-27INRCroresQuarterlyFirst quarterMulti segment2025-07-1011:30:002025-07-1015:40:00Declaration of unmodified opinion2025-04-012025-06-30AuditedConsolidated6343700000001660000000065097000000000037715000000019500000001361000000088470000000481180000000169790000000016979000000041630000000-300000004160000000001281900000000000128190000000128100000001410000000001276000000005900000001400800000009200000003620000000135.2735.270035.2735.27Cost of equipment and software licences7260000000Other expenses81210000000Banking, Financial Services and Insurance247360000000Manufacturing64010000000Consumer Business101550000000Communication, Media and Technology94360000000Life Sciences and Healthcare64220000000Others62870000000634370000000634370000000Banking, Financial Services and Insurance62160000000Manufacturing19980000000Consumer Business27990000000Communication, Media and Technology26550000000Life Sciences and Healthcare15740000000Others163300000001687500000001950000000-2990000000169790000000Banking, Financial Services and Insurance0Manufacturing0Consumer Business0Communication, Media and Technology0Life Sciences and Healthcare0Others0000Banking, Financial Services and Insurance0Manufacturing0Consumer Business0Communication, Media and Technology0Life Sciences and Healthcare0Others0000Remeasurement of defined employee benefit plans80000000Net change in fair values of investments in equity shares carried at fair value through OCI38000000046000000020000000Net change in fair values of investments other than equity shares carried at fair value through OCI2070000000Net change in intrinsic value of derivatives designated as cash flow hedges90000000Net change in time value of derivatives designated as cash flow hedges-400000000Exchange differences on translation of financial statements of foreign operations110500000001281000000044000000012810000000AuditedtrueB S R & Co. LLPtrue2025-07-31